DK160314C - Analogifremgangsmaade til fremstilling af bicycliske pyrimidin-5-on-derivater og farmaceutisk acceptable salte deraf - Google Patents
Analogifremgangsmaade til fremstilling af bicycliske pyrimidin-5-on-derivater og farmaceutisk acceptable salte derafInfo
- Publication number
- DK160314C DK160314C DK316582A DK316582A DK160314C DK 160314 C DK160314 C DK 160314C DK 316582 A DK316582 A DK 316582A DK 316582 A DK316582 A DK 316582A DK 160314 C DK160314 C DK 160314C
- Authority
- DK
- Denmark
- Prior art keywords
- analogue
- derivatives
- preparation
- acceptable salts
- pharmaceutical acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28359081A | 1981-07-15 | 1981-07-15 | |
| US28359081 | 1981-07-15 | ||
| US37065382 | 1982-04-21 | ||
| US06/370,653 US4443451A (en) | 1981-07-15 | 1982-04-21 | Bicyclic pyrimidin-5-one derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK316582A DK316582A (da) | 1983-01-16 |
| DK160314B DK160314B (da) | 1991-02-25 |
| DK160314C true DK160314C (da) | 1991-07-29 |
Family
ID=26962133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK316582A DK160314C (da) | 1981-07-15 | 1982-07-14 | Analogifremgangsmaade til fremstilling af bicycliske pyrimidin-5-on-derivater og farmaceutisk acceptable salte deraf |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4443451A (da) |
| EP (1) | EP0070053B1 (da) |
| KR (1) | KR870000868B1 (da) |
| AU (1) | AU547967B2 (da) |
| CA (1) | CA1207765A (da) |
| CS (1) | CS227690B2 (da) |
| DD (1) | DD215553A5 (da) |
| DE (1) | DE3270589D1 (da) |
| DK (1) | DK160314C (da) |
| ES (1) | ES513976A0 (da) |
| FI (1) | FI75828C (da) |
| GR (1) | GR76006B (da) |
| HU (1) | HU186952B (da) |
| IE (1) | IE53400B1 (da) |
| MA (1) | MA19536A1 (da) |
| NO (1) | NO166327C (da) |
| NZ (1) | NZ201266A (da) |
| PH (1) | PH18120A (da) |
| PL (1) | PL136680B1 (da) |
| PT (1) | PT75247B (da) |
| SU (1) | SU1138032A3 (da) |
| YU (1) | YU154682A (da) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4535081A (en) * | 1979-11-23 | 1985-08-13 | Pfizer Inc. | Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor |
| US4548938A (en) * | 1981-07-15 | 1985-10-22 | Janssen Pharmaceutica N.V. | 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds |
| US4485107A (en) * | 1982-11-01 | 1984-11-27 | Janssen Pharmaceutica N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
| GB8300728D0 (en) * | 1983-01-12 | 1983-02-16 | Erba Farmitalia | Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives |
| US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
| US4533665A (en) * | 1983-07-27 | 1985-08-06 | Janssen Pharmaceutica | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
| PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
| US4548939A (en) * | 1984-10-01 | 1985-10-22 | Janssen Pharmaceutica N. V. | 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones |
| US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
| EP0268309B1 (en) * | 1986-09-22 | 1996-12-11 | Janssen Pharmaceutica N.V. | Serotonin antagonists for treating wounds |
| DE3634532A1 (de) * | 1986-10-10 | 1988-04-14 | Basf Ag | Verfahren zur herstellung von thiazolo-(2,3-b)chinazolonen |
| US4921854A (en) * | 1986-12-30 | 1990-05-01 | Egis Gyogyszergyar | Condensed thiazolopyrimidine, pyrimido-thiazine or thiazepine pyrimidine compounds |
| IL90879A0 (en) * | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
| US5140029A (en) * | 1989-01-09 | 1992-08-18 | Janssen Pharmaceutica N.V. | 2-aminopyrimidinone derivatives |
| US5256659A (en) * | 1989-01-09 | 1993-10-26 | Janssen Pharmaceutica N.V. | 2-aminopyrimidinone derivatives |
| GB8900382D0 (en) * | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
| FR2644786B1 (fr) * | 1989-03-21 | 1993-12-31 | Adir Cie | Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| WO1992006086A1 (en) * | 1990-10-01 | 1992-04-16 | Janssen Pharmaceutica N.V. | Novel 4-piperidinylcarbonyl derivatives |
| DE4243287A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
| JPH07508741A (ja) * | 1992-07-13 | 1995-09-28 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 新規４−（３−ベンゾフラニル）ピペリジニル及び４−（３−ベンゾチエニル）ピペリジニル誘導体，ならびにそれらを含む製薬学的組成物 |
| DE4338396A1 (de) * | 1993-11-10 | 1995-05-11 | Basf Ag | N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
| ES2236700T3 (es) * | 1993-11-19 | 2005-07-16 | Janssen Pharmaceutica N.V. | 1,2-benzazoles microencapsulados. |
| TW421649B (en) * | 1995-01-31 | 2001-02-11 | Janssen Pharmaceutica Nv | 4-(1H-indol-1yl)-1-piperidinyl derivatives |
| ES2097093B1 (es) * | 1995-05-26 | 1998-01-16 | Ferrer Int | Nuevos compuestos derivados de 5h-tiazolo (3,2-a) pirimidin-5-ona. |
| US5962473A (en) * | 1996-08-16 | 1999-10-05 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F |
| US6380201B1 (en) | 1997-08-05 | 2002-04-30 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists |
| CA2395075A1 (en) * | 1999-12-16 | 2001-06-21 | Miles P. Smith | 1,3,4-substituted piperidine analogs and uses thereof in treating addictions |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| WO2004094415A1 (en) * | 2003-04-22 | 2004-11-04 | Synthon B.V. | Risperidone monohydrochloride |
| CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
| US7572249B2 (en) * | 2006-12-01 | 2009-08-11 | The Procter & Gamble Company | Merchandise display systems for baby care articles |
| US7582075B2 (en) * | 2006-08-24 | 2009-09-01 | The Procter & Gamble Company | Disposable absorbent article products with improved stages of development identification |
| KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료 |
| EP2684871B1 (en) * | 2006-12-19 | 2016-05-04 | F. Hoffmann-La Roche AG | Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| CA2728373A1 (en) * | 2008-06-18 | 2009-12-23 | F.Hoffmann-La Roche Ag | Aryl ketone as mri |
| PT2398500T (pt) | 2009-02-20 | 2019-06-14 | 2 Bbb Medicines B V | Sistema de entrega de medicamentos à base de glutationas |
| TWI556839B (zh) | 2009-05-06 | 2016-11-11 | 研究室護膚股份有限公司 | 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1306558A (en) * | 1970-08-14 | 1973-02-14 | Seperic | Derivatives of thiazolino-pyrimidin-5-ones their preparation and applications |
| GB1374281A (en) * | 1971-08-24 | 1974-11-20 | Seperic | Thiazolino-pyrimidin-5-one derivatives process for their pre paration and applications thereof |
| JPS51146497A (en) * | 1975-06-12 | 1976-12-16 | Sankyo Co Ltd | Process for preparing pyrido (1,2-a)pyrimidinone derivatives |
| US4041163A (en) * | 1976-03-29 | 1977-08-09 | Pfizer Inc. | N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents |
| GB1582744A (en) * | 1976-06-04 | 1981-01-14 | Gruenenthal Gmbh | 7h-thiazolo (and 1,3,4-thiadiazolo-)(3,2-a) pyrimidin-7-one-5-carboxylic acids derivatives and medicaments therof |
| US4471117A (en) * | 1979-06-21 | 1984-09-11 | Janssen Pharmaceutica N.V. | 3,4-Dihydro-2H-pyrimido(2,1-b)benzothiazoles |
| US4342870A (en) | 1980-03-28 | 1982-08-03 | Janssen Pharmaceutica N.V. | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
-
1982
- 1982-04-21 US US06/370,653 patent/US4443451A/en not_active Expired - Fee Related
- 1982-05-28 CA CA000403953A patent/CA1207765A/en not_active Expired
- 1982-06-02 CS CS824092A patent/CS227690B2/cs unknown
- 1982-06-17 EP EP82200751A patent/EP0070053B1/en not_active Expired
- 1982-06-17 DE DE8282200751T patent/DE3270589D1/de not_active Expired
- 1982-06-23 GR GR68542A patent/GR76006B/el unknown
- 1982-06-24 SU SU823455997A patent/SU1138032A3/ru active
- 1982-06-25 KR KR8202847A patent/KR870000868B1/ko active
- 1982-07-09 AU AU85759/82A patent/AU547967B2/en not_active Ceased
- 1982-07-14 PT PT75247A patent/PT75247B/pt not_active IP Right Cessation
- 1982-07-14 FI FI822511A patent/FI75828C/fi not_active IP Right Cessation
- 1982-07-14 DK DK316582A patent/DK160314C/da not_active IP Right Cessation
- 1982-07-14 MA MA19744A patent/MA19536A1/fr unknown
- 1982-07-14 ES ES513976A patent/ES513976A0/es active Granted
- 1982-07-14 NZ NZ201266A patent/NZ201266A/en unknown
- 1982-07-14 IE IE1689/82A patent/IE53400B1/en not_active IP Right Cessation
- 1982-07-14 NO NO822439A patent/NO166327C/no unknown
- 1982-07-15 DD DD82241675A patent/DD215553A5/de not_active IP Right Cessation
- 1982-07-15 PL PL1982237492A patent/PL136680B1/pl unknown
- 1982-07-15 YU YU01546/82A patent/YU154682A/xx unknown
- 1982-07-15 HU HU822299A patent/HU186952B/hu not_active IP Right Cessation
- 1982-07-15 PH PH27576A patent/PH18120A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK160314B (da) | 1991-02-25 |
| PL136680B1 (en) | 1986-03-31 |
| NZ201266A (en) | 1985-01-31 |
| FI75828B (fi) | 1988-04-29 |
| PT75247B (en) | 1985-01-07 |
| YU154682A (en) | 1985-03-20 |
| GR76006B (da) | 1984-08-03 |
| DD215553A5 (de) | 1984-11-14 |
| FI822511A0 (fi) | 1982-07-14 |
| PL237492A1 (en) | 1984-02-27 |
| NO822439L (no) | 1983-01-17 |
| ES8308327A1 (es) | 1983-08-16 |
| PH18120A (en) | 1985-03-22 |
| CS227690B2 (en) | 1984-05-14 |
| IE53400B1 (en) | 1988-11-09 |
| EP0070053A3 (en) | 1984-03-21 |
| AU8575982A (en) | 1983-01-20 |
| PT75247A (en) | 1982-08-01 |
| KR870000868B1 (ko) | 1987-04-30 |
| HU186952B (en) | 1985-10-28 |
| FI75828C (fi) | 1988-08-08 |
| DK316582A (da) | 1983-01-16 |
| FI822511L (fi) | 1983-01-16 |
| EP0070053A2 (en) | 1983-01-19 |
| CA1207765A (en) | 1986-07-15 |
| KR840000568A (ko) | 1984-02-25 |
| US4443451A (en) | 1984-04-17 |
| DE3270589D1 (de) | 1986-05-22 |
| NO166327C (no) | 1991-07-10 |
| EP0070053B1 (en) | 1986-04-16 |
| ES513976A0 (es) | 1983-08-16 |
| AU547967B2 (en) | 1985-11-14 |
| IE821689L (en) | 1983-01-15 |
| NO166327B (no) | 1991-03-25 |
| MA19536A1 (fr) | 1983-04-01 |
| SU1138032A3 (ru) | 1985-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK160314C (da) | Analogifremgangsmaade til fremstilling af bicycliske pyrimidin-5-on-derivater og farmaceutisk acceptable salte deraf | |
| DK165455C (da) | Analogifremgangsmaade til fremstilling af dipeptidderivater og farmaceutisk acceptable salte heraf | |
| DK161770C (da) | Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf | |
| DK163359C (da) | Analogifremgangsmaade til fremstilling af n-imidazolylderivater af bicycliske forbindelser eller pharmaceutisk acceptable salte deraf | |
| DK166381C (da) | Analogifremgangsmaade til fremstilling af (3-aminopropoxy)-bibenzylderivater og farmaceutisk acceptable salte deraf | |
| DK162444C (da) | Analogifremgangsmaade til fremstilling af azabicyklooctancarboxylsyrer og farmaceutisk acceptable salte heraf | |
| DK149449C (da) | Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf | |
| DK152287C (da) | Analogifremgangsmaade til fremstilling af carbostyril-derivater | |
| DK157860C (da) | Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf | |
| DK164917C (da) | Analogifremgangsmaade til fremstilling af bicyklisk substituerede dipeptidderivater og deres farmaceutisk acceptable salte | |
| DK158269C (da) | Analogifremgangsmaade til fremstilling af morpholinyldaunorubicin- eller morpholinyldoxorubicinderivater | |
| DK152114C (da) | Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf | |
| DK148537C (da) | Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf | |
| DK161968C (da) | Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf | |
| DK149861C (da) | Analogifremgangsmaade til fremstilling af s-adenosyl-methioninsalte | |
| DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
| DK155670C (da) | Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf | |
| DK161699C (da) | Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf | |
| DK163989C (da) | Analogifremgangsmaade til fremstilling af beta-adrenergisk blokerende forbindelser og farmaceutisk acceptable salte deraf | |
| DK84089D0 (da) | Fremgangsmaade og mellemprodukter til fremstilling af quinolinderivater og farmaceutisk acceptable salte deraf | |
| DK152115C (da) | Analogifremgangsmaade til fremstilling af fluorerede 2,5-diamino-3-pentenderivater og farmaceutisk acceptable salte deraf | |
| DK149093C (da) | Analogifremgangsmaade til fremstilling af pentapeptidderivater eller farmaceutisk acceptable salte deraf | |
| DK85183D0 (da) | Fremgangsmade til fremstilling af benzokondenserede tricycliske forbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter derved | |
| DK152491C (da) | Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf | |
| DK150521C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |